ascendis pharma glp-1 receptor agonist Schematic illustration of monoagonists, dual agonists and triple Current Insights, Advantages and Challenges
Description
Designed in an easy-to-use tablet format, this product provides a convenient alternative to injectable GLP-1 options
Promotes a healthy blood sugar response*: Reducose slows down the breakdown of carbs to reduce post-meal glucose spikes by up to 40%, while Feiolix supports insulin sensitivity and glucose metabolism.
A new GLP-1 oral medication from AstraZeneca, known as elecoglipron, lowered blood sugar levels and led to 10.5% weight loss in a phase 2b clinical trial.
Your healthcare provider or pharmacist will give you instructions on how and where to self-administer the injection
What is Retatrutide
